In April 2022, Steve Mackin will become president and CEO, and Lynn Britton will become executive chair of Mercy's board of directors.
In April 2022, Steve Mackin will succeed Lynn Britton in leading the integrated healthcare system, which serves communities in Missouri, Oklahoma, Arkansas, and Kansas. Following the transition, Britton will become executive chair of Mercy's board of directors.
"In addition to a robust succession plan, Mercy is very intentional about mapping out new strategies and innovations in health care," Britton said in a statement. "Today, we are fully engaged with Mercy’s Strategy 2025 which will continue to transform health care, so we get it right for the people we serve. As a member of our senior leadership team, Steve played an integral part in the design of this strategy and I am confident he and our entire Mercy team will continue to innovate new ways of providing compassionate care and exceptional service to our communities and patients, just as our Sisters envisioned for Mercy."
Britton, who has served as president and CEO of Mercy for the past decade, will closely work with Mackin over the coming months to ensure a smooth transition.
"I have had the privilege and honor to serve under Lynn and learn servant leadership firsthand," Mackin said in a statement. "I am humbled by the board’s decision and I will work diligently to serve our co-workers, patients and communities in a way that reflects our Sisters’ legacy – a bias for action, dignity, hospitality, right relationships and fullness for life."
Mackin joined Mercy in March 2017, and currently serves as executive vice president for the health system, and president of Mercy Hospital St. Louis. He also leads as a senior executive for business line development with an initial focus on cancer services in Mercy's eastern region.
Prior to joining Mercy, he served as a senior leader at Cancer Treatment Centers of America for nearly two decades.
Melanie Blackman is the strategy editor at HealthLeaders, an HCPro brand.